Stock Price Quote

KILITCH DRUGS (INDIA) LTD.

NSE : KILITCHBSE : 524500ISIN CODE : INE729D01010Industry : Pharmaceuticals & DrugsHouse : Private
BSE250.001.35 (+0.54 %)
PREV CLOSE ( ) 248.65
OPEN PRICE ( ) 250.00
BID PRICE (QTY) 250.50 (200)
OFFER PRICE (QTY) 249.50 (200)
VOLUME 50
TODAY'S LOW / HIGH ( )250.00 250.00
52 WK LOW / HIGH ( )121.3 248.65
NSE249.150 (0 %)
PREV CLOSE( ) 249.15
OPEN PRICE ( ) 249.15
BID PRICE (QTY) 249.15 (1731)
OFFER PRICE (QTY) 249.00 (808)
VOLUME 5514
TODAY'S LOW / HIGH( ) 249.15 249.15
52 WK LOW / HIGH ( )125 249.15
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 1992
Management Info
- Chairman Mukund P Mehta - Managing Director
Registered Office

Address C 301/2 M I D C,T T C Industrial Area,Pawane Village,
Navi Mumbai,
Maharashtra-400705

Phone 022-62996300

Email info@kilitch.com

Website www.kilitch.com

Registrars Details
Link Intime India Pvt Ltd.
C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai
Listing : BSE, NSE, MCX

NEWS

24Jul Allotment of Convertible warrants
Inter alia, approved:- 1.Obtaining credit facilities from bank not exce..
24Jul Allotment of Equity Shares
Inter alia, approved:- 1.Obtaining credit facilities from bank not exce..
22Jul Kilitch Drugs (India) informs about ou
Pursuant to Regulation 30 of SEBI (LODR) Regulations, 2015, Kilitch Drug..
19Jul Allotment of Convertible warrants
Inter alia, to consider and approve conversion of warrants into the equi..
19Jul Allotment of Equity Shares
Inter alia, to consider and approve conversion of warrants into the equi..

Financials

in Millions
QTR Jun 23 ANNUAL 23
Net Profit41.88157.18
Gross Profit 55.81 194.49
Operating Profit 62.17217.71
Net Sales 311.251177.84

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Dr. Reddy's Lab (BSE)
peergroup  5511.65 (1.33%)
M.Cap ( in Cr)91805.01
Guj. Themis Biosyn (BSE)
peergroup  919.40 (3.93%)
M.Cap ( in Cr)1332.21
Pfizer (BSE)
peergroup  3866.65 (0.80%)
M.Cap ( in Cr)17554.32
Natco Pharma (BSE)
peergroup  875.35 (3.13%)
M.Cap ( in Cr)15591.51
NGL Fine-Chem (BSE)
peergroup  2014.05 (1.08%)
M.Cap ( in Cr)1244.28

Shareholding Pattern

PROMOTERS 68.25%
NON-INSTITUTION 31.75%
FI/BANKS/INSURANCE 0%
MUTUAL FUNDS/UTI 0%
GOVERNMENT 0%
FII 0%

About Kilitch Drugs (India) Ltd.

Kilitch Drugs (India) Ltd. was incorporated in the year 1992. Its today's share price is 250. Its current market capitalisation stands at Rs 400.69 Cr. In the latest quarter, company has reported Gross Sales of Rs. 1051.6 Cr and Total Income of Rs.1097.19 Cr. The company's management includes Pushpa Nyoupane, Venkita Subramanian Rajan, Vasudev Krishna Murti, Hemang Engineer, Mira Mehta, Bhavin Mehta, Mukund P Mehta.

It is listed on the BSE with a BSE Code of 524500 , NSE with an NSE Symbol of KILITCH and ISIN of INE729D01010. It's Registered office is at C 301/2 M I D C,T T C Industrial Area,Pawane VillageNavi Mumbai-400705, Maharashtra. Their Registrars are K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.) It's auditors are AM Ghelani & Co, RNR Iyer & Co, Suryaprakash Maurya & Co

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.